Download PDF
Klinische Neurophysiologie 2013; 44(03): 213-218
DOI: 10.1055/s-0033-1343301
Der besondere Fall
© Georg Thieme Verlag KG Stuttgart · New York

Rasch progrediente Demenz: Enzephalitis oder Enzephalopathie?

Rapidly Progressive Dementia: Inflammation or Degeneration?
G. Ellrichmann
1   Department of Neurology, St. Josef Hospital, Ruhr-University Bochum
,
C. Lukas
2   Department of Radiology, St. Josef Hospital, Ruhr-University Bochum
,
W. J. Schulz-Schaeffer
3   National Reference Centre for Transmissible Spongiform Encephalopathies, Department of Neuropathology, University Medical Center Goettingen, Germany
,
C. Börnke
1   Department of Neurology, St. Josef Hospital, Ruhr-University Bochum
› Author Affiliations
Further Information

Publication History

Publication Date:
16 July 2013 (online)

Also available at
    Permissions and Reprints
Warum dieser Fall?

Unser Fall zeigt, dass eine genaue Einordnung der Genese einer rasch progredienten Demenz trotz vermeintlich typischer klinischer Symptome und ausführlicher diagnostischer Maßnahmen (Bildgebung, EEG, Labor- und Liquoranalysen) oft erst durch eine Hirnbiopsie oder die Hirnsektion möglich ist. Die Therapie sollte bis zur Sicherung der Diagnose mögliche Differenzialdiagnosen berücksichtigen.

 

  • Literatur

  • 1 Schulz-Schaeffer WJ, Tschöke S, Kranefuss N et al. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 2000; 156: 51-56
    CrossrefPubMedGoogle Scholar
  • 2 Edler J, Mollenhauer B, Heinemann U et al. Movement disturbances in the differential diagnosis of Creutzfeldt-Jakob disease. Mov Disord 2009; 24: 350-356
    CrossrefPubMedGoogle Scholar
  • 3 Voltz R, Blaes F, Rauer S, Weller M. Paraneoplastisches Syndrom. Leitlinien für Diagnostik und Therapie in der Neurologie. 4.. überarbeitete Auflage, Stuttgart: Thieme; 2008
    Google Scholar
  • 4 Sakai K. Recent advances in paraneoplastic encephalomyeloneuronopathy. Nihon Rinsho 1994; 52: 3006-3012
    PubMedGoogle Scholar
  • 5 Graus F, Keime-Guibert F, Rene R et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001; 124: 1138-1148
    CrossrefPubMedGoogle Scholar
  • 6 Dalmau J, Graus F, Rosenblum MK et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992; 71: 59-72
    CrossrefPubMedGoogle Scholar
  • 7 Chitravas N, Jung RS, Kofskey DM et al. Treatable Neurological Disorders Misdiagnosed as Creutzfeldt-Jakob Disease. Ann Neurol 2011; 70: 437-444
    CrossrefPubMedGoogle Scholar
  • 8 Leitlinien für Diagnostik und Therapie in der Neurologie. 4.. überarbeitete Auflage, Stuttgart: Thieme; 2008
    Google Scholar
  • 9 Parchi P, Giese A, Capellari S et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233
    CrossrefPubMedGoogle Scholar
  • 10 Castellani RJ, Colucci M, Xie Z et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-442
    CrossrefPubMedGoogle Scholar
  • 11 Collins SJ, Sanchez-Juan P, Masters CL et al. Determinants of diagnostic investigation sensivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129: 2278-2287
    CrossrefPubMedGoogle Scholar
  • 12 Satoh K, Shirabe S, Tsujino A et al. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2007; 24: 207-212
    CrossrefPubMedGoogle Scholar
  • 13 Tschampa HJ, Kallenberg K, Meissner B et al. Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease. Am J Neurorad 2007; 28: 1114-1118
    PubMedGoogle Scholar
  • 14 Galanaud D, Dormont D, Haik S et al. Differences of apparant diffusion coefficient values in patients with Creutzfeldt-Jakob disease according tot he codon 129 genotype. Am J Neuroradiol 2008; 29: E57
    CrossrefPubMedGoogle Scholar
  • 15 Meissner B, Kallenberg K, Sanchez-Juan P et al. Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt-Jakob disease. Am J Neurorad 2008; 29: 1519-1524
    PubMedGoogle Scholar
  • 16 Zerr I, Kallenberg K, Summers DM et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-2668
    CrossrefPubMedGoogle Scholar
  • 17 Foote M, Zhou Y. 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 2012; 3: 152-164
    PubMedGoogle Scholar
  • 18 Zerr I, Pocchiari M, Collins S et al. Analysis of EEF and CSF 14-3-3 protein as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-815
    CrossrefPubMedGoogle Scholar
  • 19 Zeidler M, Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 analysis. Neurology 2004; 63: 410-411
    CrossrefPubMedGoogle Scholar
  • 20 Chang CC, Eggers SD, Johnson JK et al. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2007; 109: 54-57
    CrossrefPubMedGoogle Scholar
  • 21 Geschwind MD, Tan KM, Lennon VA et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008; 65: 1341-1346
    CrossrefPubMedGoogle Scholar
  • 22 Schott JM, Reiniger L, Thom M et al. Brain biopsy in dementia: clinical indications and diagnostic approach. Acta Neuropathol 2010; 120: 327-341
    CrossrefPubMedGoogle Scholar
  • 23 Wemheuer WM, Benestad SL, Wrede A et al. Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am J Pathol 2009; 175: 2566-2573
    CrossrefPubMedGoogle Scholar
  • 24 Interdisziplinärer Experten-Konsens im Arbeitskreis „Krankenhaus- & Praxishygiene“ der AWMF. AWMF Leitlinie 029/025: Prophylaxe der Creutzfeldt-Jakob-Erkrankung in Krankenhaus und Praxis. www.awmf.org/uploads/tx_szleitlinien/029-025l_S1_Prophylaxe_Creutzfeld-Jakob-Erkrankung.pdf (Stand 01/2012)
    Google Scholar